Combined Therapeutics
PrivateLast Round
Early Funding
Mar 8, 2023
Total Funding Raised
$500,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Combined Therapeutics is a biotechnology company that develops mRNA-based vaccines and therapeutics for infectious diseases and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Combined Therapeutics Comparables
Compare Combined Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strand Therapeutics | 81% | |
| aceRNA Technologies Co., Ltd. | 81% | |
| Kernal Biologics | 81% |
Combined Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 8, 2023 | ||||
| Grant | Sep 25, 2020 | ||||
| Seed | Dec 12, 2017 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 169% MoM, reaching 2.7K.
- Apr 2, 2026
Monthly visitors increased 64% MoM.
Combined Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Combined Therapeutics's valuation, stock price, and market status.
Is Combined Therapeutics a public or private company?
Combined Therapeutics is a private company.
What is the current stock price of Combined Therapeutics?
Combined Therapeutics is a private company with no public stock price. Caplight tracks Combined Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Combined Therapeutics worth (valuation)?
Valuation information for Combined Therapeutics is not publicly available.
Can I buy Combined Therapeutics stock?
Combined Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Combined Therapeutics's last funding round?
Combined Therapeutics's most recent funding round was Early Funding on March 8, 2023.
Who are the main investors in Combined Therapeutics?
Investor information for Combined Therapeutics is not publicly disclosed.
Will Combined Therapeutics IPO soon?
No public IPO plans have been announced for Combined Therapeutics.
How can I track Combined Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Combined Therapeutics's secondary market activity and sign up for updates.